Kiyoshi Yamaguchi
- Molecular Biology top 10%
- Immunology top 5%
- Oncology top 10%
- Physiology top 5%
- Rheumatology top 5%
- Co-authors
- Seung Joon BaekYoichi FurukawaSeong‐Ho LeeThomas E. ElingJong‐Sik KimTsuneo IkenoueSeiya ImotoSeira Hatakeyama
- Topics
- Cancer-related gene regulation (15 papers)Epigenetics and DNA Methylation (11 papers)Wnt/β-catenin signaling in development and cancer (10 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Kiyoshi Yamaguchi
107 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.2k
- Immunology 511
- Oncology 374
- Physiology 372
- Rheumatology 352
Countries citing papers authored by Kiyoshi Yamaguchi
This map shows the geographic impact of Kiyoshi Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Yamaguchi more than expected).
Fields of papers citing papers by Kiyoshi Yamaguchi
This network shows the impact of papers produced by Kiyoshi Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Yamaguchi. The network helps show where Kiyoshi Yamaguchi may publish in the future.
Co-authorship network of co-authors of Kiyoshi Yamaguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Yamaguchi. A scholar is included among the top collaborators of Kiyoshi Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Yamaguchi. Kiyoshi Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 16 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 8 | |
| 13 | Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypesbreakdown → | 278 |
| 14 | 14 | |
| 15 | 7 | |
| 16 | 11 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | [Falls in patients with dementia]. | 2 |
| 20 | 135 |
About Kiyoshi Yamaguchi
Kiyoshi Yamaguchi is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Immunology, having authored 114 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related gene regulation (15 papers), Epigenetics and DNA Methylation (11 papers) and Wnt/β-catenin signaling in development and cancer (10 papers). The work is most often cited by research in Immunology (511 citations), Rheumatology (352 citations) and Applied Microbiology and Biotechnology (42 citations). Kiyoshi Yamaguchi has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Seung Joon Baek, Yoichi Furukawa, Seong‐Ho Lee, Thomas E. Eling, Jong‐Sik Kim, Tsuneo Ikenoue, Seiya Imoto, Seira Hatakeyama, Eigo Shimizu and Makoto Nakanishi. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.